Germany
Japan
United Kingdom
China
Research Areas
Download
USD 379.00
In Stock
USD 420.00
4 Weeks
USD 420.00
4 Weeks
USD 159.00
2 Days
USD 420.00
4 Weeks
MAP3K7 mouse monoclonal antibody,clone OTI9D2
| Applications | WB |
| Reactivities | Human, Rat |
| Conjugation | Unconjugated |
Special Offer: Get a 15% discount on this product. Use code: "KO15".
CRP mouse monoclonal antibody,clone OTI1G10
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Special Offer: Get a 15% discount on this product. Use code: “NEURO15".
USD 420.00
4 Weeks
USD 420.00
4 Weeks
RPS6KA2 mouse monoclonal antibody,clone OTI2G5
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
ROR2 mouse monoclonal antibody,clone OTI5E3
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
ROR2 mouse monoclonal antibody,clone OTI5E3, Biotinylated
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Biotin |
ROR2 mouse monoclonal antibody,clone OTI5E3, HRP conjugated
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | HRP |
ROR2 mouse monoclonal antibody,clone OTI5E3
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
USD 420.00
4 Weeks
ST2 mouse monoclonal antibody, clone OTI1B5B8
ST2 mouse monoclonal antibody, clone OTI1B5B8
ST2 mouse monoclonal antibody, clone OTI1H4C4
ST2 mouse monoclonal antibody, clone OTI1H4C4
ST2 mouse monoclonal antibody, clone OTI1H5
ST2 mouse monoclonal antibody, clone OTI1H5
ST2 mouse monoclonal antibody, clone OTI1H1
ST2 mouse monoclonal antibody, clone OTI1H1
ST2 mouse monoclonal antibody, clone OTI2F1
ST2 mouse monoclonal antibody, clone OTI2F1
ST2 mouse monoclonal antibody, clone OTI1E4
ST2 mouse monoclonal antibody, clone OTI1E4
ST2 mouse monoclonal antibody, clone OTI1E1
ST2 mouse monoclonal antibody, clone OTI1E1
Active filters
Category
- Antibodies
Antibody Hosts
- Mouse
Filter by
Target Symbol
- IL6 (130)
- CD4 (120)
- PECAM1 (109)
- IL1RL1 (102)
- PTPRC (88)
- CD99 (84)
- PDCD1 (84)
- CD19 (77)
- LGALS3 (77)
- KIT (71)
- CD68 (70)
- CD5 (65)
- MS4A1 (63)
- CD34 (61)
- NCAM1 (59)
- TNFRSF8 (51)
- CR2 (45)
- WNT3 (45)
- CD2 (39)
- MME (38)
- ESR1 (37)
- FCER2 (36)
- TYRO3 (36)
- CD22 (35)
- CRP (35)
- DVL2 (35)
- IL1RN (35)
- MAPK8 (34)
- CD274 (33)
- ANAPC11 (31)
- CD8A (31)
- ANAPC2 (30)
- ROR2 (30)
- CD33 (29)
- CD14 (28)
- CD79B (28)
- IL2RA (26)
- MAPK9 (26)
- CSF3 (23)
- IL3RA (22)
- ANPEP (19)
- TNF (19)
- CD3E (18)
- FCGR1A (15)
- MAPK10 (15)
- PTK7 (15)
- RORA (15)
- POSTN (14)
- CD74 (12)
- ITGB3 (12)
- CD79A (11)
- IL2 (11)
- IL6R (11)
- CD7 (10)
- IL36G (10)
- AGTPBP1 (9)
- IL12B (8)
- IL1A (8)
- IL6ST (8)
- ROR1 (8)
- FCGR3A (7)
- TLR8 (7)
- CD1A (5)
- ESR2 (5)
- HLA-DRB5 (5)
- ITGA2B (5)
- LEF1 (5)
- TOLLIP (5)
- CALR (4)
- CD163 (4)
- IL1B (4)
- IL36A (4)
- CRYGD (3)
- CXCL8 (3)
- HLA-A (3)
- IL6RA (3)
- WNT3A (3)
- CD46 (2)
- FUT4 (2)
- HLA-DQA2 (2)
- HLA-G (2)
- IL18 (2)
- ITGAX (2)
- TLR3 (2)
- TMED1 (2)
- ANAPC5 (1)
- ARAF (1)
- BRAF (1)
- CASP1 (1)
- CD10 (1)
- CD207 (1)
- CD30 (1)
- CDC42SE2 (1)
- CKMT2 (1)
- ELK3 (1)
- HLA CLASS II (1)
- IL10 (1)
- IL1R1 (1)
- IL1R2 (1)
- IRS1 (1)
Reactivities
Applications
Isotypes
Clonalities
Conjugates
Carrier-free
Knockout (KO) Validation
Modifications
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (5)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (1)
Assay Types
Assay Platforms
Families
- Druggable Genome (2194)
- Transmembrane (1734)
- ES Cell Differentiation/IPS (802)
- Secreted Protein (614)
- Adult stem cells (310)
- Protein Kinase (250)
- Embryonic stem cells (157)
- Stem cell - Pluripotency (118)
- Induced pluripotent stem cells (116)
- Phosphatase (87)
- Transcription Factors (84)
- Cancer stem cells (63)
- Protease (63)
- Nuclear Hormone Receptor (56)
- Stem cell relevant signaling - Wnt Signaling pathway (4)
- Stem cell relevant signaling - JAK/STAT signaling pathway (1)
Pathways
- Hematopoietic cell lineage (1024)
- Cell adhesion molecules (CAMs) (740)
- T cell receptor signaling pathway (389)
- Cytokine-cytokine receptor interaction (383)
- Pathways in cancer (374)
- Primary immunodeficiency (330)
- Toll-like receptor signaling pathway (286)
- Jak-STAT signaling pathway (235)
- NOD-like receptor signaling pathway (230)
- Prion diseases (199)
- Leukocyte transendothelial migration (196)
- B cell receptor signaling pathway (194)
- Graft-versus-host disease (179)
- Antigen processing and presentation (170)
- Wnt signaling pathway (166)
- Melanogenesis (160)
- Hypertrophic cardiomyopathy (HCM) (159)
- Progesterone-mediated oocyte maturation (142)
- MAPK signaling pathway (141)
- Cytosolic DNA-sensing pathway (135)
- Colorectal cancer (119)
- Fc gamma R-mediated phagocytosis (110)
- RIG-I-like receptor signaling pathway (105)
- Endocytosis (99)
- Fc epsilon RI signaling pathway (97)
- Focal adhesion (96)
- Adipocytokine signaling pathway (94)
- Type II diabetes mellitus (94)
- Basal cell carcinoma (89)
- ErbB signaling pathway (85)
- Neurotrophin signaling pathway (83)
- Insulin signaling pathway (82)
- Acute myeloid leukemia (81)
- Epithelial cell signaling in Helicobacter pylori infection (81)
- GnRH signaling pathway (80)
- Pancreatic cancer (79)
- Lysosome (69)
- Oocyte meiosis (63)
- Cell cycle (62)
- Ubiquitin mediated proteolysis (62)
- Type I diabetes mellitus (58)
- Alzheimer's disease (55)
- Renin-angiotensin system (53)
- Regulation of actin cytoskeleton (52)
- Apoptosis (51)
- Hedgehog signaling pathway (49)
- Allograft rejection (47)
- Complement and coagulation cascades (46)
- Systemic lupus erythematosus (45)
- Notch signaling pathway (35)
- Natural killer cell mediated cytotoxicity (33)
- Pathogenic Escherichia coli infection (32)
- Dilated cardiomyopathy (30)
- Asthma (24)
- Autoimmune thyroid disease (23)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (19)
- Metabolic pathways (19)
- Amyotrophic lateral sclerosis (ALS) (18)
- Glutathione metabolism (18)
- TGF-beta signaling pathway (17)
- ECM-receptor interaction (13)
- Viral myocarditis (13)
- Chemokine signaling pathway (10)
- Endometrial cancer (10)
- Prostate cancer (10)
- Adherens junction (8)
- Thyroid cancer (7)
- Bladder cancer (6)
- Chronic myeloid leukemia (6)
- Glioma (6)
- Renal cell carcinoma (6)
- Non-small cell lung cancer (5)
- VEGF signaling pathway (5)
- Vascular smooth muscle contraction (5)
- Long-term potentiation (4)
- Melanoma (4)
- mTOR signaling pathway (4)
- Axon guidance (3)
- Gap junction (3)
- Long-term depression (3)
- Small cell lung cancer (3)
- Tight junction (3)
- Arginine and proline metabolism (1)
- Dorso-ventral axis formation (1)
- Inositol phosphate metabolism (1)
- Phosphatidylinositol signaling system (1)
- Vibrio cholerae infection (1)